STENTiT is a medical device spin-off company from the Dutch Eindhoven University of Technology, focusing on the development of regenerative endovascular implants. These bioresorbable devices trigger a natural healing response by the circulating blood cells, in which the implant is being replaced by new vascular tissue to restore the artery from the inside-out.
Since the establishment of the company in 2017, STENTiT has received broad international recognition and awards for its high-potential approach, covering world leading stages. As the company is currently going through the next translational phases, STENTiT is on its way to fulfill its ambition to become the new standard in endovascular treatment, providing a life-lasting solution for millions of patients around the world.
Company Details
- Employees
- 17
- Founded
- -
- Address
- Eindhoven, Noord Brabant 5612 Ap, Nl
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.stentit.com
- HQ
- Eindhoven, Noord Brabant
Stentit Questions
Stentit's website is http://www.stentit.com
Stentit's LinkedIn profile is https://nl.linkedin.com/company/stentit
Stentit has
17 employees.
View email and phone details for 17
employees at Stentit.
Stentit's industry is
Medical Equipment Manufacturing
Stentit's top competitors are
Smart Biomaterials Consortium (Sbmc),
Microsure,
Sirius Medical,
Xeltis,
Onera Health,
Cardiacbooster,
Conform Medical,
Amt Medical,
Vivolta,
Toro Neurovascular.
Stentit's categories are Medical Equipment Manufacturing
Stentit's founding year is 2017
